New-Onset A-Fib Profiled in Patients Hospitalized With COVID-19
New-onset atrial fibrillation identified in about 1 in 20 patients hospitalized with COVID-19
Viral Infections
Presence of Particulate Prompts Recall of Acyclovir Intravenous Product
The administration of recalled product may lead to inflammation, allergic reactions, or circulatory system complications.
Bivalent mRNA-1273.214 Elicits Better Response Against Omicron
Booster dose of mRNA-1273.214 elicits more neutralizing antibodies against omicron compared with mRNA-1273, with no new safety concerns
USPSTF Recommends Syphilis Screening for At-Risk Persons
Substantial net benefit observed for screening of nonpregnant persons at increased risk for infection
CDC Says Universal Masking Can Be Dropped in Some Nursing Homes, Hospitals
Masking ‘remains recommended’ during an outbreak among patients or ‘when caring for patients who are moderately to severely immunocompromised’
Pfizer, BioNTech Seek to Extend Authorization for Omicron-Adapted Booster to Children
The bivalent vaccine contains the original strain of the SARS-CoV-2 virus and a strain from the BA.4 and BA.5 lineages of the Omicron variant.
Norovirus Outbreaks Have Increased to Prepandemic Levels
In surveillance year 2021 to 2022, 992 outbreaks were reported compared with 1,056 and 343 in 2019 to 2020 and 2020 to 2021
Performance of COVID-19 Rapid Antigen Tests With Nasal Self-Sampling Examined
Sensitivities of rapid antigen tests with nasal self-sampling declined during period of omicron emergence
Risk of Monkeypox Transmission Low in Health Care Settings
No health care providers developed monkeypox infection during the 21 days after exposure
Full-Dose Anticoagulation Beneficial for Critically Ill With COVID-19
However, no significant difference seen in efficacy or safety outcomes for clopidogrel versus no antiplatelet therapy
